Immunosuppression following organ transplantation is a known risk factor for the development of lymphoproliferative disorders.Mycosis fungoides, a rare entity in pediatric patients, has seldom been reported as a post-transplant lymphoproliferative disorder.We report a case of folliculotropic mycosis fungoides in a pediatric patient following liver transplantation that was initially diagnosed as tinea capitis.
| 387Pediatric Dermatology BRIEF REPORT majority are B-cell lymphomas, while primary cutaneous T-cell lymphoma (CTCL) is rare. 1 Mycosis fungoides (MF), the most common primary CTCL, typically occurs in adults over age 50. 2 Childhood MF as a post-transplant lymphoproliferative disorder (PTLD) has seldom been demonstrated.One case of classic MF in a 16-year-old following liver transplantation initially presented as a non-pruritic plaque on the back. 3 The area resolved with narrowband ultraviolet B light therapy, and no changes were made to his immunosuppression. 3 A second case of FMF in a 13-year-old following renal transplantation presented as widespread psoriasiform plaques, some ulcerated, along with alopecic patches with follicular plugging on the scalp. 4 He was on sirolimus, tacrolimus, and prednisone for immunosuppression. Sirolimus was discontinued given the presence of ulcerations and the higher incidence of wound complications compared to tacrolimus, with the patient achieving partial clinical remission. 4,5 Folliculotropic mycosis fungoides accounts for only 4% of the CTCLs, though it may be more common in post-transplant patients compared to the general population. 4,6 This variant is less responsive to typical treatments, and the prognosis is similar to that of classic tumor-stage MF. 6 In addition to topical treatments, our patient's immunosuppression regimen was altered, since reduction or cessation of immunosuppression can be effective in treating PTLDs. 7 Furthermore, the conversion of immunosuppression to sirolimus, an mTOR inhibitor, has also been shown to increase remission rates, possibly due to the additional antineoplastic effect of mTOR inhibitors. 7,8 Multiple biopsies are often needed to make the diagnosis of MF, as seen in our case and the two previously reported cases. 3,4 The presence of black dots on physical exam and fungal elements within the hair shaft were diagnostic red herrings in this case. A second set of biopsies was necessary to confirm the correct diagnosis of FMF.While rare, it is important for dermatologists to consider MF in the differential diagnosis in a child following solid organ transplantation. Repeat biopsies must be obtained if MF is suspected to prevent misdiagnosis and delay of treatment.